Lack of efficacy of rituximab in Felty's syndrome

Ann Rheum Dis. 2005 Feb;64(2):332-3. doi: 10.1136/ard.2004.025643.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / therapeutic use*
  • Felty Syndrome / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Rituximab
  • Treatment Failure

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab